The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program
- PMID: 25783204
- PMCID: PMC6550306
- DOI: 10.1017/ice.2015.43
The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program
Abstract
Objective: To determine the potential epidemiologic and economic value of the implementation of a multifaceted Clostridium difficile infection (CDI) control program at US acute care hospitals
Design: Markov model with a 5-year time horizon
Participants: Patients whose data were used in our simulations were limited to hospitalized Medicare beneficiaries ≥65 years old.
Background: CDI is an important public health problem with substantial associated morbidity, mortality, and cost. Multifaceted national prevention efforts in the United Kingdom, including antimicrobial stewardship, patient isolation, hand hygiene, environmental cleaning and disinfection, and audit, resulted in a 59% reduction in CDI cases reported from 2008 to 2012.
Methods: Our analysis was conducted from the federal perspective. The intervention we modeled included the following components: antimicrobial stewardship utilizing the Antimicrobial Use and Resistance module of the National Healthcare Safety Network (NHSN), use of contact precautions, and enhanced environmental cleaning. We parameterized our model using data from CDC surveillance systems, the AHRQ Healthcare Cost and Utilization Project, and literature reviews. To address uncertainty in our parameter estimates, we conducted sensitivity analyses for intervention effectiveness and cost, expenditures by other federal partners, and discount rate. Each simulation represented a cohort of 1,000 hospitalized patients over 1,000 trials. RESULTS In our base case scenario with 50% intervention effectiveness, we estimated that 509,000 CDI cases and 82,000 CDI-attributable deaths would be prevented over a 5-year time horizon. Nationally, the cost savings across all hospitalizations would be $2.5 billion (95% credible interval: $1.2 billion to $4.0 billion).
Conclusions: The potential benefits of a multifaceted national CDI prevention program are sizeable from the federal perspective.
Conflict of interest statement
Figures
Similar articles
-
Vital signs: preventing Clostridium difficile infections.MMWR Morb Mortal Wkly Rep. 2012 Mar 9;61(9):157-62. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22398844
-
Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.Infect Control Hosp Epidemiol. 2015 Jun;36(6):695-701. doi: 10.1017/ice.2015.37. Epub 2015 Mar 10. Infect Control Hosp Epidemiol. 2015. PMID: 25753106 Free PMC article.
-
Clostridium difficile: improving the prevention paradigm in healthcare settings.Expert Rev Anti Infect Ther. 2014 Sep;12(9):1087-102. doi: 10.1586/14787210.2014.942284. Expert Rev Anti Infect Ther. 2014. PMID: 25109301 Review.
-
A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection.Infect Control Hosp Epidemiol. 2017 Jul;38(7):777-783. doi: 10.1017/ice.2017.76. Epub 2017 May 2. Infect Control Hosp Epidemiol. 2017. PMID: 28462761 Clinical Trial.
-
Strategies for prevention of Clostridium difficile infection.J Hosp Med. 2012 Mar;7 Suppl 3:S14-7. doi: 10.1002/jhm.1908. J Hosp Med. 2012. PMID: 22407995 Review.
Cited by
-
Practical Concerns about the Metrics and Methods of Financial Outcome Measurement in Antimicrobial Stewardship Programs: A Narrative Review.Iran J Med Sci. 2022 Sep;47(5):394-405. doi: 10.30476/ijms.2021.92213.2343. Iran J Med Sci. 2022. PMID: 36117584 Free PMC article. Review.
-
Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention.JAC Antimicrob Resist. 2020 Aug 11;2(3):dlaa037. doi: 10.1093/jacamr/dlaa037. eCollection 2020 Sep. JAC Antimicrob Resist. 2020. PMID: 34223003 Free PMC article.
-
Development and validation of a time and motion guide to assess the costs of prevention and control interventions for nosocomial infections: A Delphi method among experts.PLoS One. 2020 Nov 12;15(11):e0242212. doi: 10.1371/journal.pone.0242212. eCollection 2020. PLoS One. 2020. PMID: 33180833 Free PMC article.
-
Intestinal bile acids directly modulate the structure and function of C. difficile TcdB toxin.Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6792-6800. doi: 10.1073/pnas.1916965117. Epub 2020 Mar 9. Proc Natl Acad Sci U S A. 2020. PMID: 32152097 Free PMC article.
-
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review.Antimicrob Resist Infect Control. 2019 Feb 12;8:35. doi: 10.1186/s13756-019-0471-0. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30805182 Free PMC article.
References
-
- Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009: Statistical Brief #124 Healthcare Cost and Utilization Project (HCUP) Statistical Briefs Rockville, MD: Agency for Health Care Policy and Research, 2006. - PubMed
-
- Bradley T, Topoleski J. An overview of the medicare program Congressional Budget office; website. http://www.cbo.gov/publication/44587. Published 2013. Accessed May 2014.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
